IDEAS home Printed from https://ideas.repec.org/a/nat/nature/v564y2018i7735d10.1038_s41586-018-0774-y.html
   My bibliography  Save this article

Disruption of a self-amplifying catecholamine loop reduces cytokine release syndrome

Author

Listed:
  • Verena Staedtke

    (Ludwig Center and the Howard Hughes Medical Institute at the Johns Hopkins Kimmel Cancer Center
    Johns Hopkins University School of Medicine)

  • Ren-Yuan Bai

    (Johns Hopkins University School of Medicine)

  • Kibem Kim

    (Ludwig Center and the Howard Hughes Medical Institute at the Johns Hopkins Kimmel Cancer Center)

  • Martin Darvas

    (University of Washington)

  • Marco L. Davila

    (H. Lee Moffitt Cancer Center and Research Institute)

  • Gregory J. Riggins

    (Johns Hopkins University School of Medicine)

  • Paul B. Rothman

    (Johns Hopkins University School of Medicine)

  • Nickolas Papadopoulos

    (Ludwig Center and the Howard Hughes Medical Institute at the Johns Hopkins Kimmel Cancer Center)

  • Kenneth W. Kinzler

    (Ludwig Center and the Howard Hughes Medical Institute at the Johns Hopkins Kimmel Cancer Center)

  • Bert Vogelstein

    (Ludwig Center and the Howard Hughes Medical Institute at the Johns Hopkins Kimmel Cancer Center)

  • Shibin Zhou

    (Ludwig Center and the Howard Hughes Medical Institute at the Johns Hopkins Kimmel Cancer Center)

Abstract

Cytokine release syndrome (CRS) is a life-threatening complication of several new immunotherapies used to treat cancers and autoimmune diseases1–5. Here we report that atrial natriuretic peptide can protect mice from CRS induced by such agents by reducing the levels of circulating catecholamines. Catecholamines were found to orchestrate an immunodysregulation resulting from oncolytic bacteria and lipopolysaccharide through a self-amplifying loop in macrophages. Myeloid-specific deletion of tyrosine hydroxylase inhibited this circuit. Cytokine release induced by T-cell-activating therapeutic agents was also accompanied by a catecholamine surge and inhibition of catecholamine synthesis reduced cytokine release in vitro and in mice. Pharmacologic catecholamine blockade with metyrosine protected mice from lethal complications of CRS resulting from infections and various biotherapeutic agents including oncolytic bacteria, T-cell-targeting antibodies and CAR-T cells. Our study identifies catecholamines as an essential component of the cytokine release that can be modulated by specific blockers without impairing the therapeutic response.

Suggested Citation

  • Verena Staedtke & Ren-Yuan Bai & Kibem Kim & Martin Darvas & Marco L. Davila & Gregory J. Riggins & Paul B. Rothman & Nickolas Papadopoulos & Kenneth W. Kinzler & Bert Vogelstein & Shibin Zhou, 2018. "Disruption of a self-amplifying catecholamine loop reduces cytokine release syndrome," Nature, Nature, vol. 564(7735), pages 273-277, December.
    • Handle: RePEc:nat:nature:v:564:y:2018:i:7735:d:10.1038_s41586-018-0774-y
    DOI: 10.1038/s41586-018-0774-y
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/s41586-018-0774-y
    File Function: Abstract
    Download Restriction: Access to the full text of the articles in this series is restricted.
    File URL: https://libkey.io/10.1038/s41586-018-0774-y?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Ruoxuan Xiong & Allison Koenecke & Michael Powell & Zhu Shen & Joshua T. Vogelstein & Susan Athey, 2021. "Federated Causal Inference in Heterogeneous Observational Data," Papers 2107.11732, arXiv.org, revised Apr 2023.

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:nature:v:564:y:2018:i:7735:d:10.1038_s41586-018-0774-y. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.